2-mercaptopyrazine

tumor necrosis factor ; Homo sapiens







23 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35080036 Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study. 2022 May 2
2 33272733 Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease. 2021 May 1
3 33813036 Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy. 2021 1
4 32232050 Long-Term Prognosis of Japanese Patients with Crohn's Disease Treated by Switching Anti-Tumor Necrosis Factor-α Antibodies. 2020 Feb 1
5 32363635 Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease. 2020 Jun 1
6 29079905 Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn's Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability. 2018 Feb 4
7 29655835 Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. 2018 Aug 2
8 28045204 Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study. 2017 Jun 1
9 26511478 Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients. 2016 Jan 1
10 26978723 Thiopurine Metabolism in the Era of Combotherapy. 2016 Jun 1
11 27063728 Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection. 2016 Jul 1
12 28028358 Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective. 2016 Dec 14 1
13 25600263 Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease. 2015 Apr 1
14 26130995 Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future. 2015 Jul 1
15 26226548 Effect of Inflammatory Bowel Disease-Related Characteristics and Treatment Interventions on Cardiovascular Disease Incidence. 2015 Sep 1
16 23978351 Phenotypic features of Crohn's disease associated with failure of medical treatment. 2014 Mar 2
17 25267954 Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System. 2014 Sep 1
18 23662928 Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy. 2013 Oct 3
19 23987103 Cancer risk in immune-mediated inflammatory diseases (IMID). 2013 Aug 29 1
20 20888436 A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. 2011 Jan 1
21 22031357 Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. 2011 Dec 2
22 20932143 Thiopurine therapy in inflammatory bowel disease. 2010 Oct 1
23 19716247 [Inflammatory bowel disease: from sulfasalazine to biologics]. 2009 Aug-Sep 1